ɾ³ý»ò¸üÐÂÐÅÏ¢£¬ÇëÓʼþÖÁfreekaoyan#163.com(#»»³É@)

¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-¶­³¤ÖÎ

±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ/2021-05-26

¶­³¤ÖÎ
DONG?CHANGZHI
****

ËùÊôѧԺ£º
ÇṤ»¯¹¤Ñ§Ôº

µ¼Ê¦Àà±ð£º
²©Ê¿Éúµ¼Ê¦¡¢Ë¶Ê¿Éúµ¼Ê¦

Ö°¡¡¡¡Îñ£º
ÎÞ

¿ÆÑз½Ïò£º
¶­³¤ÖνÌÊڵĿÆÑй¤×÷Ö÷ÒªÉæ¼°µ½Á½´óÁìÓò£ºÔÚÐÂÒ©Ñз¢·½Ã棬ÖÂÁ¦ÓÚ¾ßÓÐDZÔÚÖÎÁƼÛÖµµÄÓлúС·Ö×ÓµÄÉè¼Æ¡¢»¯Ñ§ºÏ³É¼°¹¹Ð§¹ØϵÑо¿£¬ÔøÏȺóÔÚ¿¹°¬×̲¡£¬¿¹Ñ×£¬¿¹ÀÏÄê³Õ´ôÖ¢£¬¿¹Ö×ÁöµÈÁìÓò¿ªÕ¹¹ýÑо¿¹¤×÷¡£ÔÚ¶àëļ°µ°°×Öʺϳɡ¢½á¹¹Ó빦ÄÜÑо¿·½Ã棬ÔøÏȺóÓû¯Ñ§È«ºÏ³ÉµÄ·½·¨µÃµ½¹ý¶à¸ö¾ßÓÐÉúÎï»îÐԵĵ°°×ÖÊ·Ö×Ó¼°ÆäÑÜÉúÎ¶Ô²ûÃ÷µ°°×ÖʽṹÓ빦ÄܵĹØϵÌṩÁËÇ¿ÓÐÁ¦µÄ¹¤¾ß¡£ÖµµÃÇ¿µ÷µÄÊÇ£¬1998Ä껯ѧȫºÏ³ÉÈËÀàIIAÐÍì¢Ëáõ¥Ã¸£¨PLA2£¬?È«³¤124¸ö°±»ùËᣬº¬7¸öÁòÁò¼ü£©µÄ¹¤×÷Ôø¾­ÊÇÊÀ½çµÚÒ»¡£½ØÖÁÄ¿Ç°£¬ÒÑ·¢±íSCIÂÛÎĽü60ƪ¡£


ÁªÏµ·½Ê½£º
**??ÁõÀÏʦ

²©Ê¿ÕÐÉúѧԺ£º
ÇṤ»¯¹¤Ñ§Ôº

˶ʿÕÐÉúѧԺ£º
ÇṤ»¯¹¤Ñ§Ôº


¸öÈ˼òÊö
(ÏÞ300×Ö)
¶­³¤ÖΣ¬ÄУ¬1962ÄêÉú£¬·¨¹ú°ÍÀèµÚÆß´óѧ½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£¬¹ã¶«¹¤Òµ´óѧ****£¬½­ºº´óѧ½»²æѧ¿ÆÑо¿Ôº¶àëļ°µ°°×ÖÊ»¯Ñ§¼°ÆäÉúÎïҽѧӦÓÃÑо¿ÖÐÐÄÊ×ϯר¼Ò¡£1983ÄêÓÚ±±¾©´óѧ¼¼ÊõÎïÀíϵ»ñѧʿѧλ£»1986ÄêÓÚ±±¾©´óѧ¼¼ÊõÎïÀíϵ»ñ˶ʿѧλ£»1986-1990ÄêÔÚɽ¶«ÑĮ̀´óѧÈÎÖú½Ì¡¢½²Ê¦£»1990-1991ÄêÔÚ·¨¹úÔ­×ÓÄÜ×ÜÊðCadaracheÑо¿ÖÐÐÄ×ö·ÃÎÊ****£»1996ÄêÓÚ·¨¹ú°ÍÀèµÚÎå´óѧҩѧԺ»ñÒ©Îﻯѧ²©Ê¿Ñ§Î»£¬Ê¦´Ó·¨À¼Î÷¿ÆѧԺԺʿBernard?P.?Roques½ÌÊÚ£»1996-1997ÄêÔÚ·¨¹ú°ÍÀè¸ßµÈʦ·¶´óѧ·¨À¼Î÷¿ÆѧԺԺʿMarc?Julia½ÌÊÚÖ¸µ¼Ï´Óʲ©Ê¿ºóÑо¿¡£1997Äê9ÔÂÆðÈη¨¹ú°ÍÀèµÚÆß´óѧ(°ÍÀèµÒµÂÂÞ´óѧ)·Ö×ÓÒ©ÎﻯѧʵÑéÊÒ½²Ê¦¡¢¸±½ÌÊÚ£¬Æڼ䣬ÔøÓÚ2001-2003?Äê¼äÔÚÃÀ¹ú?UIUC?´óѧ×ö·ÃÎÊ****£¬ÓÚ2003Äêµ×»ñµÃ²©µ¼×ʸñ£»ÓÚ2009Äê¼ÓÃË·¨¹ú°ÍÀèµÚÆß´óѧºÍ·¨¹ú¹ú¼Ò¿ÆѧÑо¿ÖÐÐĹ²½¨µÄITODYSʵÑéÊÒ£¬²¢ÓÚ2011Äê½úÉýΪ½ÌÊÚ¡£Ä¿Ç°Îª·¨¹ú°ÍÀèµÚÆß´óѧ»¯Ñ§ÏµÑ§ÊõίԱ»á³ÉÔ±£¬BC2T˶ʿµã»¯Ñ§ºÍÒ½ÁÆ(Chemistry?and?Therapeutics)רҵ¸ºÔðÈË£¬È«·¨Öйú¿Æ¼¼¹¤×÷ÕßЭ»á¸±Àíʳ¤£¬ºþ±±Ê¡³þÌì****½²×ù½ÌÊÚ(2011-)¡£

ѧ¿ÆÁìÓò
¿Æѧѧλ£º
»¯Ñ§¹¤³ÌÓë¼¼Êõ

רҵѧλ£º
»¯Ñ§¹¤³Ì


½ÌÓý±³¾°
¡ö???1992/09¡ª1996/09??·¨¹ú°ÍÀèµÚÎå´óѧҩѧԺ£¬Ò©Îﻯѧ£¬²©Ê¿
¡ö 1983/09¡ª1986/07??±±¾©´óѧ¼¼ÊõÎïÀíϵ£¬·ÅÉ仯ѧ£¬Ë¶Ê¿
¡ö 1979/09¡ª1983/07??±±¾©´óѧ¼¼ÊõÎïÀíϵ£¬·ÅÉ仯ѧ£¬Ñ§Ê¿


¹¤×÷¾­Àú
¡ö???2009/01¡ªÖÁ½ñ??????·¨¹ú°ÍÀèµÚÆß´óѧITODYSʵÑéÊÒ£¬½ÌÊÚ
¡ö???2001/07¡ª2003/01???ÃÀ¹úUIUC´óѧÉúÎïϵ£¬·ÃÎÊ****
¡ö???1997/09¡ª2008/12???·¨¹ú°ÍÀèµÚÆß´óѧ·Ö×ÓÒ©ÎïÉúÎïʵÑéÊÒ£¬½²Ê¦£¬¸±½ÌÊÚ
¡ö???1996/10¡ª1997/08???·¨¹ú°ÍÀè¸ßµÈʦ·¶´óѧ»¯Ñ§Ïµ£¬²©Ê¿ºó
¡ö???1990/10¡ª1991/09???·¨¹úÔ­×ÓÄÜ×ÜÊð?Cadarache?Ñо¿ÖÐÐÄ?£¬·ÃÎÊ****
¡ö???1986/07¡ª1990/07???ÑĮ̀´óѧ?£¬Éú»¯Ïµ?£¬Öú½Ì?£¬½²Ê¦


ѧÊõ¼æÖ°
¶­³¤ÖνÌÊÚÔøÊÜƸΪÀ¼ÖÝ´óѧ(1997-2000,?2006-2009)¡¢ÖпÆԺн®Àí»¯¼¼ÊõÑо¿Ëù(2006-2009)¡¢¹ã¶«¹¤Òµ´óѧ(2009-2012)µÈ¿Í×ù½ÌÊÚ£¬ÉϺ£½»Í¨´óѧҩѧԺÆÀ¹ÀίԱ»áº£Íâר¼Ò£¨2008£©£»Öйú¿ÆѧԺ¡¢¹ú¼ÒÍâ¹úר¼Ò¾Ö¹ú¼ÊºÏ×÷»ï°é¼Æ»®´´ÐÂÍŶӺ£Íâ³ÉÔ±(2009-2013)£¬À¼ÖÝ´óѧÝÍÓ¢½²Ï¯½ÌÊÚ(2009-2012)?£¬¹ã¶«¹¤Òµ´óѧ****(2011-)£¬·¨¹úPharmaleads¹«Ë¾¹ËÎÊ£¨2006-£©£¬ºþ±±Ê¡³þÌì****½²×ù½ÌÊÚ(2011-)¡£


Ö÷ÒªÈÙÓþ
Ôø»ñ·¨¹ú°ÍÀèµÚÆß´óѧ2007Äê¶È·¢Ã÷´´Ð¹ÄÀø½±


Ö÷ÒªÂÛÎÄ
1.Wang,?X.;?Piro,?B.;?Reisberg,?S.;?Anquetin,?G.;?De?Rocquigny,?H.;?Jiang,?P.;?Wang,?Q.;?Wu,,?W.;?Pham,?M.-C.;?Dong,?C.-Z.*(2014)?¡°Direct,?Reagentless?Electrochemical?Detection?of?the?BIR3?Domain?of?X-linked?Inhibitor?of?Apoptosis?Protein?Using?a?Peptide-based?Conducting?Polymer?Sensor¡±,?Biosens?Bioelectron,?61,?57-62.
2.Wang,?X.;?Reisberg,?S.;?Serradji,?N.;?Anquetin,?G.;?Pham,?M.-C.;?Wu,?W.;?Dong,?C.-Z.;?Piro,?B.?(2014)?¡°E-assay?concept:?Detection?of?bisphenol?A?with?a?label-free?electrochemical?competitive?immunoassay¡±,?Biosens?Bioelectron,?53,?214-219.
3.He,?Y.-W.;?Dong,?C.-Z.;?Zhao,?J-Y;?Ma,?L.-L.?;?Li,?Y.-H.;?Aisa?H.?A.?(2014),?¡°1,?2,?3-Triazole-containing?derivatives?of?rupestonic?acid:?Click-chemical?synthesis?and?antiviral?activities?against?influenza?viruses¡±,?Eur.?J.?Med.?Chem.,?76,?245-55.
4.Shi?J.,?Chen?J.,?Serradji?N.,?Xu?X.,?Zhou?H.,?Ma?Y.,?Sun?Z.,?Jiang?P.,?Du?Y.,?Yang?J;,?Dong?C.-Z.,?Wang?Q.?(2013),?¡°PMS1077?Sensitizes?TNF-¦Á?Induced?Apoptosis?in?Human?Prostate?Cancer?Cells?by?Blocking?NF-¦ÊB?Signaling?Pathway¡±,?PLoS?One.,?8,?e61132.
5.Dong,?C.-Z.;?Tian?S,?Choi?WT,?Kumar?S,?Liu?D,?Xu?Y,?Han?X,?Huang?Z,?An?J.?(2012)?¡°Critical?Role?in?CXCR4?Signaling?and?Internalization?of?the?Polypeptide?Main?Chain?in?the?Amino?Terminus?of?SDF-1¦Á?Probed?by?Novel?N-Methylated?Synthetically?and?Modularly?Modified?Chemokine?Analogues¡±,?Biochemistry,?51,?5951-7.
6.N?Griffete,?H.?Li,?A.?Lamouri,?C.?Redeuilh,?K.?Chen,?C.-Z.?Dong,?S.?Nowak,?S.?Ammar,?C.?Mangeney?(2012),?¡°Magnetic?nanocrystals?coated?by?molecularly?imprinted?polymers?for?the?recognition?of?bisphenol?A¡±,?J?Mater?Chem.,?22,?1807-1811.
7.Eggert,?D.;?Dash,?P.?K.;?Serradji,?N.;?Dong,?C.?Z.;?Clayette,?P.;?Heymans,?F.;?Dou,?H.;?Gorantla,?S.;?Gelbard,?H.?A.;?Poluektova,?L.;?Gendelman,?H.?E.?(2009)?¡°Development?of?a?platelet-activating?factor?antagonist?for?HIV-1?associated?neurocognitive?disorders¡±,?J?Neuroimmunol.,?213,?47-59.
8.Ezoulin,?J.?M.;?Shao,?B.?Y.;?Xia,?Z.;?Xie,?Q.;?Li,?J.;?Cui,?Y.?Y.;?Wang,?H.;?Dong,?C.?Z.;?Zhao,?Y.?X.;?Massicot,?F.;?Qiu,?Z.?B.;?Heymans,?F.;?Chen,?H.?Z.?(2009)?¡°Novel?piperazine?derivative?PMS1339?exhibits?tri-functional?properties?and?cognitive?improvement?in?mice¡±,?Int?J?Neuropsychopharmacol.,?12,?1409-19.
9.Touaibia,?M.;?Djimd¨¦,?A.;?Cao,?F.;?Boilard,?E.;?Bezzine,?S.;?Lambeau,?G.;?Redeuilh,?C.;?Lamouri,?A.;?Massicot,?F.;?Chau,?F.;?Dong,?C.?Z.;?Heymans,?F.?(2007)?¡°?Inhibition?of?secreted?phospholipase?A2?(sPLA2).?4-Glycerol?derivatives?of?4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one?(PMS1062)?with?broad?activities?¡±,?J.?Med.?Chem.,?50,?1618-26.
10.Dong,?C.?Z.;?Kumar,?S.;?Choi,?W.?T.;?Madani,?N.;?Tian,?S.;?An,?J.;?Sodroski,?J.?G.;?Huang?Z.?(2005)?¡°Different?stereochemical?requirements?for?CXCR4?binding?and?signaling?functions?as?revealed?by?an?anti-HIV,?D-amino?acid-containing?SMM-chemokine?ligand¡±,?J.?Med.?Chem.,?48,?7923-4.
11.Serradji,?N.;?Bensaid,?O.;?Martin,?M.;?Cisternino,?S.;?Rousselle,?C.;?Huet,?J.;?Redeuilh,?C.;?Lamouri,?A.;?Dong,?C.?Z.;?Clayette,?P.;?Godfroid,?J.-J.;?Scherrmann,?J.-M.;?Dormont,?D.;?Heymans,?F.?(2004)?¡°Structure-activity?relationships?in?Platelet-Activating?Factor.?12.?Synthesis?and?biological?evaluation?of?Platelet-Activating?Factor?antagonists?with?anti-HIV-1?activity¡±,?J.?Med.?Chem.,?47,?6410-9.
12.Dong,?C.?Z.;?Romieu,?A.;?Mounier,?C.?M.;?Heymans,?F.;?Roques,?B.?P.;?Godfroid,?J.-J.?(2002)??¡°Total?direct?chemical?synthesis?and?biological?activities?of?human?group?IIA?secretory?phospholipase?A2¡±,?Biochem.?J.,?365,?505-11.


¿ÆÑÐÏîÄ¿
1.½­ºº´óѧ½»²æѧ¿ÆÑо¿Ôº¶àëļ°µ°°×ÖÊ»¯Ñ§¼°ÆäÉúÎïҽѧӦÓÃÑо¿ÖÐÐÄÊ×ϯר¼ÒʵÑéÊÒ½¨ÉèºÍ»î¶¯¾­·Ñ£º2011-,800ÍòÔª,?ÔÚÑÐ,?Ö÷³Ö.
2.¹ã¶«¹¤Òµ´óѧ****Æô¶¯¾­·Ñ?:?2011-:100ÍòÔª,?ÔÚÑÐ,?Ö÷³Ö.
3.Novartis,?Development?of?peptide?mimics?of?platelet?glycoprotein?VI?as?collagen?tracer?and?antagonist,?2010-2013:160?000?€£¬ÒѽáÌ⣬²ÎÓë.
4.Universit¨¦?Paris?Diderot,???Projets?interdisciplinaires?Paris?Diderot?2011?,?Synthesis?of?3-isoxazolidinone?derivatives?and?their?anti-bacteria?activity?against?Chlamydia?trachomatis,?2010-2011?:25?000?€,?ÒѽáÌ⣬Ö÷³Ö
5.Universit¨¦?Paris?Diderot,???Projets?interdisciplinaires?Paris?Diderot??,?Development?of?peptide?mimics?of?platelet?glycoprotein?VI?as?collagen?tracer?and?antagonist,?2009-2010:25?000?€£¬ÒѽáÌ⣬²ÎÓë
6.Paris?Centre?Universit¨¦,?new?oxadiazolone?derivatives?with?anti-inflammatory?and?anti-cytokine?properties,?2008-2009:?10?000?€£¬ÒѽáÌ⣬Ö÷³Ö
7.ARC,?inhibitors?of?XIAP?as?new?anticancer?agents,?2007-2009:?50?000?€£¬ÒѽáÌ⣬Ö÷³Ö
8.Laboratories?SERVIER,?inhibitors?of?XIAP?as?new?anticancer?agents,?2006-2007:?35?000?€£¬ÒѽáÌ⣬Ö÷³Ö
9.BTG,?Toxicity?and?pharmacokinetic?study?of?PMS?601,?a?dual?anti-PAF?and?anti-HIV?compound,?2001£¬2?°ÙÍò·¨ÀÉ,ÒѽáÌ⣬²ÎÓë
10.Action?Concert¨¦e?Interdisciplinaire,?Inhibitors?of?PLA2?and?treatment?of?inflammation,?2000-2002£¬8?°ÙÍò·¨ÀÉ,ÒѽáÌ⣬²ÎÓë
11.YANIKEM?s.a.,?Inhibitors?of?PLA2?and?treatment?of?inflammation,?1998-2002£¬5?°ÙÍò·¨ÀÉ,ÒѽáÌ⣬²ÎÓë



Ïà¹Ø»°Ìâ/ÇṤ »¯¹¤Ñ§Ôº

  • ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æ¿¼Ñп¼ÊÔ×ÊÁÏ!
    ´ó¶îÓÅ»Ýȯ
    ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îп¼Ñп¼ÊÔ¿¼Ö¤Ààµç×Ó´òÓ¡×ÊÁÏÈÎÄãÑ¡¡£º­¸ÇÈ«¹ú500ÓàËùԺУ¿¼ÑÐרҵ¿Î¡¢200¶àÖÖÖ°Òµ×ʸñ¿¼ÊÔ¡¢1100¶àÖÖ¾­µä½Ì²Ä£¬²úÆ·ÀàÐÍ°üº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì××ÊÁÏÒÔ¼°ÊÓƵ£¬ÎÞÂÛÄúÊÇ¿¼Ñи´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...
    ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖѧϰÍø 2022-09-19
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-»ôÑÓƽ
    ÐÕÃû:»ôÑÓƽ,ÄУ¬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£¬ÏÖÈÎÇṤ»¯¹¤Ñ§Ôº¸±Ôº³¤£»¹ã¶«Ê¡¿ÆÑм°Éú»¯¼ì²âÓÃÊÔ¼Á¹¤³Ì¼¼ÊõÑо¿ÖÐÐÄÖ÷ÈΡ£¹ã¶«Ê¡¡°Ç§°ÙÊ®¹¤³Ì¡±Ê¡¼¶ÅàÑø¶ÔÏ󣻹㶫¹¤Òµ´óѧ¿ÆÑÐÀà¡°ÅàÓ¢Óý²Å¡±µÚÒ»²ã´ÎÈËÑ¡£»¹ã¶«Ê¡Óлú»¯Ñ§×¨ÒµÎ¯Ô±»áίԱ;¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðͨѶÆÀÉóר¼Ò£»ÔÚÓлú·¢¹âOLED²ÄÁÏ¡¢ÓлúÌ«ÑôÄܵç³Ø¡¢º£ÉÏ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-Àî³É³¬
    Àî³É³¬½ÌÊÚµç×ÓÓʼþ£ºlicc@gdut.edu.cn¸öÈ˼ò½é:²©Ê¿Éúµ¼Ê¦£¬¹ú¼Ò¼¶¸ß²ã´ÎÈ˲ţ¬ÇàÄêÖé½­****£¬¹ã¶«Ê¡Öé½­È˲ÅÇàÄê°Î¼âÈ˲š£¶«Ý¸îÒ´óÌØÖÖ´¢ÄÜÑо¿ÔººËÐijÉÔ±¡£Ö÷Òª´ÓʸßÐÔÄÜ´¢ÄܲÄÁÏÓëÆ÷¼þµÄÑо¿¡£·¢Õ¹³ö¾§Ïàµ÷¿Ø¼¼Êõ£¬²å²ã»¯Ñ§µ÷¿Ø¼¼ÊõÌáÉýµç¼«Àë×ÓǨÒÆÂÊ£»½¨Á¢Á˵Íά¿×²ÄÁϺϳɷ½·¨Ñ§£¬¸ÄÉÆÀë×ÓÀ© ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ÁõÈ«±ø
    ÁõÈ«±øLiuQuanbing½ÌÊÚËùÊôµ¥Î»£ºÇṤ»¯¹¤Ñ§Ôº£¬»¯Ñ§¹¤³ÌϵͨÐŵØÖ·£º¹ãÖÝÊдóѧ³ÇÍâ»·Î÷·100ºÅ¹¤Ñ§ËĺŹÝ611Ñо¿ÁìÓò£ºÐÂÄÜÔ´²ÄÁÏÓëÆ÷¼þ1)ï®/ï®Àë×Ó/ï®Áòµç³Ø£»2)µç´ß»¯/ȼÁϵç³Ø£»3£©³¬¼¶µçÈÝÆ÷£»4£©°±ÅðÍé´ß»¯ÖÆÇ⡣ѧ¿ÆÁìÓò£º¿Æѧѧλ£º»¯Ñ§¹¤³ÌÓë¼¼Êõרҵѧλ£º»¯Ñ§¹¤³ÌÁªÏµ·½Ê½£ºliuq ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ÇØÑÓÁÖ
    ÇØÑÓÁÖ(QINYANLIN)£¬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡¢Ë¶Ê¿Éúµ¼Ê¦Ö°Îñ£º¿ÆÑÐÔº¸±Ôº³¤(¼æ)ÁªÏµ·½Ê½ÓÊÏ䣺ylqin@gdut.edu.cnÇØÑÓÁÖ£¬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦£¬¹ã¶«Ê¡****¿Æѧ»ù½ð»ñµÃÕߣ¬¹ã¶«¹¤Òµ´óѧ¡°ÇàÄê****¡±£¬¹ã¶«Ê¡½ÌÓýÌüÇàÄê´´ÐÂÈ˲ţ¬2018ÄêÈιú¼Ò×ÔÈ»¿Æѧ»ù½ðίԱ»áÁ÷Ïî¡£»ªÄÏÀí ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ÍõÌú¾ü
    ÍõÌú¾üWANGTIEJUN½ÌÊÚËùÊôѧԺ£ºÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦Àà±ð£º²©Ê¿/˶ʿÉúµ¼Ê¦Ñо¿·½Ïò£ºÉúÎïÄÜÔ´¡¢ÄÜÔ´Óë»·¾³´ß»¯¡¢È¼ÁÏ»¯Ñ§¡¢µÍ̼¼¼ÊõÁªÏµ·½Ê½£ºµç»°£º´«Õ棺µç×ÓÓʼþ£ºtjwang@gdut.edu.cn²©Ê¿ÕÐÉúѧԺ£ºÇṤ»¯¹¤Ñ§ÔºË¶Ê¿ÕÐÉúѧԺ£ºÇṤ»¯¹¤Ñ§Ôº¸öÈ˼òÊö£ºÍõÌú¾ü£¬ÄУ¬1972Äê9ÔÂÉú£¬¹ã¶«¹¤Òµ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ÇñѧÇà
    ÇñѧÇàQIUXUEQING½ÌÊÚËùÊôѧԺ£ºÇṤ»¯¹¤Ñ§Ôº²©Ê¿Éú/˶ʿÉúµ¼Ê¦¸öÈ˼òÊö£ºÇñѧÇ࣬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£ÏÖÈι㶫¹¤Òµ´óѧУ³¤¡£¹úÎñÔºÌØÊâ½òÌùר¼Ò£¬¹ú¼Ò****¿Æѧ»ù½ð»ñµÃÕߣ¬ÈëÑ¡¹ú¼ÒÐÂÊÀ¼Í¡°°ÙǧÍò¡±È˲Ź¤³Ì¡£¼æÈÎÖйú»¯¹¤Ñ§»áÀíÊ¡¢¾«Ï¸»¯¹¤×¨ÒµÎ¯Ô±»á¸±Ö÷ÈΣ¬¹ã¶«Ê¡»¯¹¤Ñ§»áÖ´ÐÐÀíʳ¤£¬¹ã¶«Ê¡ÂÌÉ« ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ÓàÁÖ
    ÓàÁÖ£¨YULIN£©½ÌÊÚµ¼Ê¦Àà±ð£º²©Ê¿Éú/˶ʿÉúµ¼Ê¦²©Ê¿±ÏÒµÓÚÖйú¿ÆѧԺ´óÁ¬»¯Ñ§ÎïÀíÑо¿Ëù£¬1994ÄêÔÚ·¨¹ú¹ú¼ÒÑо¿ÖÐÐÄÀï°º´ß»¯Ñо¿Ëù£¨CNRS-IRC£©½øÐкÏ×÷¹¤×÷£¬´ÓʵÍ̼ÍéÌþ´ß»¯×ª»¯µÄÑо¿£»1995Äêµ×ÓÚËÄ´¨´óѧÆƸñ½úÉýΪ½ÌÊÚ¡£ÏÖΪ¹ã¶«¹¤Òµ´óѧ¸±Ð£³¤£¬¼æÈÎÈ«¹ú¾«Ï¸»¯¹¤×¨ÃÅίԱ»áίԱ£¬¹ã¶«Ê¡µÚÎå¡¢ ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-Bernard?Meunier
    BernardMeunierԺʿ£¬****ËùÊôѧԺ£ºÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦Àà±ð£º²©Ê¿Éúµ¼Ê¦¡¢Ë¶Ê¿Éúµ¼Ê¦¿ÆÑз½Ïò£ºÁªÏµ·½Ê½£ºbmeunier@lcc-toulouse.fr²©Ê¿ÕÐÉúѧԺ£ºÇṤ»¯¹¤Ñ§ÔºË¶Ê¿ÕÐÉúѧԺ£ºÇṤ»¯¹¤Ñ§ÔºÑ§¿ÆÁìÓò¿Æѧѧλ£ºÓ¦Óû¯Ñ§×¨ÒµÑ§Î»£º½ÌÓý±³¾°¡°DoctoratdeTroisi¨¨me ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-ºúÉý
    ºúÉýHUSHENG½ÌÊÚËùÊôѧԺ£ºÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦Àà±ð£ºË¶Ê¿Éúµ¼Ê¦¿ÆÑз½Ïò£ºÅäλ»¯Ñ§Ó빦ÄÜ·Ö×Ó²ÄÁÏÁªÏµ·½Ê½£ºhusheng@gdut.edu.cn˶ʿÕÐÉúѧԺ£ºÇṤ»¯¹¤Ñ§Ôº¸öÈ˼òÊöºúÉý£¬²©Ê¿£¬½ÌÊÚ£¬Ö÷Òª´ÓÊÂÅäλ¾ÛºÏÎï²ÄÁϵÄ×é×°¹æÂɼ°½á¹¹µ÷¿ØÓëÐÔÖÊÑо¿¡¢¹¦ÄܴغÏÎïÓ뺬½ðÊô´ØµÄÓлú¨CÎÞ»úÔÓ»¯²ÄÁϵÄÉè¼ÆºÏ³É ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26
  • ¹ã¶«¹¤Òµ´óѧÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦½Ìʦʦ×ʽéÉܼò½é-·½ÑÒÐÛ
    ·½ÑÒÐÛFANGYANXIONG½ÌÊÚËùÊôѧԺ£ºÇṤ»¯¹¤Ñ§Ôºµ¼Ê¦Àà±ð£º²©Ê¿Éúµ¼Ê¦¡¢Ë¶Ê¿Éúµ¼Ê¦Ö°¡¡¡¡Îñ£ºÔº³¤¿ÆÑз½Ïò£ºÖ÷Òª´ÓÊÂÂÌÉ«»¯Ñ§Ó빤ÒÕ·½ÃæÑо¿Ìرð¹Ø×¢Àë×ÓÒºÌåµÄÓ¦ÓÃʯÓÍ»¯¹¤ºÍ¾«Ï¸»¯Ñ§ºÏ³É¸ß´¿ÊÔ¼ÁÖƱ¸£¬ÎïÖʵķÖÀëÓëÌá´¿¹Å¼®ºÍµµ°¸µÄ±£»¤ÓëÐÞ¸´µÈÁªÏµ·½Ê½£ºµç»°£º´«Õ棺µç×ÓÓʼþ£ºfangyx@gdut.ed ...
    ±¾Õ¾Ð¡±à Free¿¼Ñп¼ÊÔ 2021-05-26